In univariable analyses, individuals with PASC tended to have lower levels of sCD14, IL10, IL17, IL1β, IL6 and TNFα (Fig 1) compared to participants without PASC at 9–12 weeks after COVID-19 onset. This evidence concerns the gene IL1B and COVID-19.